tiprankstipranks

KemPharm announces two new additions to its senior management team

KemPharm announced that it has named Daniel Gallo, Ph.D., as Senior Vice President of Medical Affairs and Advocacy, and Abbi Maher, J.D., as Vice President of Legal Affairs. Both positions are newly created at KemPharm and continue a series of enhancements to the Company’s leadership to support its transformation into a leading rare disease company. Dr. Gallo joins KemPharm from Jaguar Gene Therapy. Maher joins KemPharm from Cytel.

Confident Investing Starts Here:

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on KMPH:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue